Metra Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Firm announces the European launch of the QUS-2 ultrasonometer for use in diagnosing osteoporosis and assessing fracture risk. The portable, battery-powered device evaluates a patient's "bone quality by measuring specific characteristics of the human heel." U.S. clinical trials are underway in preparation for a premarket approval application to FDA in the next few months